Abstract | BACKGROUND:
Pulmonary fibrosis (PF), the end point of interstitial lung diseases, is characterized by myofibroblast over differentiation and excessive extracellular matrix accumulation, leading to progressive organ dysfunction and usually a terminal outcome. Studies have shown that umbilical cord-derived mesenchymal stromal cells (uMSCs) could alleviate PF; however, the underlying mechanism remains to be elucidated. METHODS: The therapeutic effects of uMSC-derived extracellular vesicles (uMSC-EVs) on PF were evaluated using bleomycin (BLM)-induced mouse models. Then, the role and mechanism of uMSC-EVs in inhibiting myofibroblast differentiation were investigated in vivo and in vitro. RESULTS: Treatment with uMSC-EVs alleviated the PF and enhanced the proliferation of alveolar epithelial cells in BLM-induced mice, thus improved the life quality, including the survival rate, body weight, fibrosis degree, and myofibroblast over differentiation of lung tissue. Moreover, these effects of uMSC-EVs on PF are likely achieved by inhibiting the transforming growth factor-β (TGF-β) signaling pathway, evidenced by decreased expression levels of TGF-β2 and TGF-βR2. Using mimics of uMSC-EV-specific miRNAs, we found that miR-21 and miR-23, which are highly enriched in uMSC-EVs, played a critical role in inhibiting TGF-β2 and TGF-βR2, respectively. CONCLUSION: The effects of uMSCs on PF alleviation are likely achieved via EVs, which reveals a new role of uMSC-EV-derived miRNAs, opening a novel strategy for PF treatment in the clinical setting.
|
Authors | Liyan Shi, Jing Ren, Jiping Li, Dongxu Wang, Yusu Wang, Tao Qin, Xiuying Li, Guokun Zhang, Chunyi Li, Yimin Wang |
Journal | Stem cell research & therapy
(Stem Cell Res Ther)
Vol. 12
Issue 1
Pg. 230
(04 12 2021)
ISSN: 1757-6512 [Electronic] England |
PMID | 33845892
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Transforming Growth Factor beta
- Bleomycin
- Transforming Growth Factors
|
Topics |
- Animals
- Bleomycin
(toxicity)
- Extracellular Vesicles
- Mesenchymal Stem Cells
- Mice
- Pulmonary Fibrosis
(chemically induced, genetics, therapy)
- Signal Transduction
- Transforming Growth Factor beta
(genetics)
- Transforming Growth Factors
- Umbilical Cord
|